Travere Therapeutics (TVTX) Shares Outstanding (Diluted) (2012 - 2026)
Travere Therapeutics' Weighted Average Shares Outstanding (Diluted) was 94.63 million in Q3 2026, down 7.8% from 102.62 million a year earlier but up 1.2% from the prior quarter.
Powered by 
Analysis
Travere Therapeutics (TVTX) Shares Outstanding (Diluted) (2012 - 2026) Analysis & Trends
For FY2025, Weighted Average Shares Outstanding (Diluted) at Travere Therapeutics came in at 89.21 million, up 13.1% from FY2024.
- Weighted Average Shares Outstanding (Diluted) has now increased for 12 consecutive years, with a five-year compound annual growth rate of 13.4% (FY2020 to FY2025).
- In earlier years, Weighted Average Shares Outstanding (Diluted) was 78.89 million in FY2024 (+6.2%), 74.27 million in FY2023 (+16.5%), 63.76 million in FY2022 (+6.6%) and 59.83 million in FY2021 (+25.9%).
- Quarterly Weighted Average Shares Outstanding (Diluted) has moved between 59.83 million (Q4 2021) and 102.62 million (Q3 2025) over five years.
- Compared with a year earlier, Weighted Average Shares Outstanding (Diluted) was higher in seven of the last eight quarters, with growth averaging 10.2%.
- The best year-over-year quarter for Weighted Average Shares Outstanding (Diluted) over five years was Q3 2025 (growth of 31.9%); the worst was Q3 2026 (a decline of 7.8%).
- Per Business Quant data, TVTX's Weighted Average Shares Outstanding (Diluted) in the three quarters before Q3 2026 was 93.48 million (Q2 2026), 91.87 million (Q1 2026) and 89.21 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 893.40 Mn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 2.45 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 1.77 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 2.48 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | 1.96 Bn |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 1.56 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 546.00 Mn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 1.25 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 5.75 Bn |
| 10 | Travere Therapeutics | 4.97 Bn | 4.56 Bn | 221.70 Mn | 94.63 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 94.63 Mn |
| Jun 30, 2026 | 93.48 Mn |
| Mar 31, 2026 | 91.87 Mn |
| Dec 31, 2025 | 89.21 Mn |
| Sep 30, 2025 | 102.62 Mn |
| Jun 30, 2025 | 88.95 Mn |
| Mar 31, 2025 | 88.36 Mn |
| Dec 31, 2024 | 78.89 Mn |
| Sep 30, 2024 | 77.78 Mn |
| Jun 30, 2024 | 77.50 Mn |
| Mar 31, 2024 | 77.14 Mn |
| Dec 31, 2023 | 74.27 Mn |
| Sep 30, 2023 | 76.31 Mn |
| Jun 30, 2023 | 76.00 Mn |
| Mar 31, 2023 | 68.17 Mn |
| Dec 31, 2022 | 63.76 Mn |
| Sep 30, 2022 | 64.03 Mn |
| Jun 30, 2022 | 63.64 Mn |
| Mar 31, 2022 | 63.13 Mn |
| Dec 31, 2021 | 59.83 Mn |
API Access
Travere Therapeutics Shares Outstanding (Diluted) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=TVTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding-diluted", "ticker": "TVTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=TVTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();